Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
28
pubmed:dateCreated
2005-9-29
pubmed:abstractText
We evaluated predictors of prostate cancer-specific mortality (PCSM) after prostate-specific antigen (PSA) failure after radical prostatectomy (RP) or radiation therapy (RT).
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0732-183X
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
23
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
6992-8
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:16192586-Aged, pubmed-meshheading:16192586-Aged, 80 and over, pubmed-meshheading:16192586-Biopsy, pubmed-meshheading:16192586-Cohort Studies, pubmed-meshheading:16192586-Combined Modality Therapy, pubmed-meshheading:16192586-Databases, Factual, pubmed-meshheading:16192586-Follow-Up Studies, pubmed-meshheading:16192586-Humans, pubmed-meshheading:16192586-Male, pubmed-meshheading:16192586-Middle Aged, pubmed-meshheading:16192586-Neoplasm Staging, pubmed-meshheading:16192586-Predictive Value of Tests, pubmed-meshheading:16192586-Prognosis, pubmed-meshheading:16192586-Prostate-Specific Antigen, pubmed-meshheading:16192586-Prostatectomy, pubmed-meshheading:16192586-Prostatic Neoplasms, pubmed-meshheading:16192586-Retrospective Studies, pubmed-meshheading:16192586-Risk Assessment
pubmed:year
2005
pubmed:articleTitle
Predictors of prostate cancer-specific mortality after radical prostatectomy or radiation therapy.
pubmed:affiliation
Department of Radiation Oncology, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Boston, MA, USA. pzhou@partners.org
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Multicenter Study